Weaver Consulting Group’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-300
Closed -$5K 809
2020
Q3
$5K Hold
300
﹤0.01% 699
2020
Q2
$5K Hold
300
﹤0.01% 670
2020
Q1
$5K Hold
300
﹤0.01% 572
2019
Q4
$5K Hold
300
﹤0.01% 624
2019
Q3
$5K Buy
300
+145
+94% +$2.42K ﹤0.01% 609
2019
Q2
$3K Hold
155
﹤0.01% 675
2019
Q1
$3K Buy
+155
New +$3K ﹤0.01% 1255